{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T05:39:55Z","timestamp":1783575595043,"version":"3.55.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T00:00:00Z","timestamp":1630281600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T00:00:00Z","timestamp":1630281600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s00431-021-04243-4","type":"journal-article","created":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T15:03:53Z","timestamp":1630335833000},"page":"579-586","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Vitamin D and nonalcoholic fatty liver disease in children: a randomized controlled clinical trial"],"prefix":"10.1007","volume":"181","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7836-1170","authenticated-orcid":false,"given":"Doaa","family":"El Amrousy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Abdelhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Shawky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,30]]},"reference":[{"issue":"6","key":"4243_CR1","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1002\/hep.23593","volume":"51","author":"EK Speliotes","year":"2010","unstructured":"Speliotes EK, Massaro JM, Hoffmann U, Vasan RS, Meigs JB, Sahani DV, Hirschhom JN, O\u2019Donnell CJ, Fox CS (2010) Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study. Hepatology 51(6):1979\u20131987","journal-title":"Hepatology"},{"issue":"1167","key":"4243_CR2","first-page":"74","volume":"44","author":"JW Haukeland","year":"2006","unstructured":"Haukeland JW, Dam\u00e5s JK, Konopski Z, L\u00f8berg EM, Haaland T, Goverud I, Torjesen PA, Birkeland K, Bj\u00f8ro K, Aukrust P (2006) Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2. J Hepatol 44(1167):74","journal-title":"J Hepatol"},{"issue":"175","key":"4243_CR3","first-page":"82","volume":"18","author":"M Flores","year":"2005","unstructured":"Flores M (2005) A role of vitamin D in low intensity chronic inflammation and insulin resistance in type 2 diabetes mellitus? Nutr Res Rev 18(175):82","journal-title":"Nutr Res Rev"},{"issue":"10","key":"4243_CR4","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.2337\/db08-0593","volume":"57","author":"NG Forouhi","year":"2008","unstructured":"Forouhi NG, Luan JA, Cooper A, Boucher BJ, Wareham NJ (2008) Baseline serum 25\u2013hydroxy vitamin D is predictive of future glycemic status and insulin resistance. Diabetes 57(10):2619\u20132625","journal-title":"Diabetes"},{"issue":"6","key":"4243_CR5","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1507\/endocrj.EJ12-0387","volume":"60","author":"EJ Rhee","year":"2013","unstructured":"Rhee EJ, Kim MK, Park SE, Park CY, Baek KH, Lee WY, Kang MI, Park SW, Kim SW, Oh KW (2013) High serum vitamin D levels reduce the risk for nonalcoholic fatty liver disease in healthy men independent of metabolic syndrome. Endocr J 60(6):743\u2013752","journal-title":"Endocr J"},{"issue":"1","key":"4243_CR6","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/1741-7015-9-85","volume":"9","author":"I Barchetta","year":"2011","unstructured":"Barchetta I, Angelico F, Ben MD, Baroni MG, Pozzilli P, Morini S, Cavallo MG (2011) Strong association between non-alcoholic fatty liver disease (NAFLD) and low 25 (OH) vitamin D levels in an adult population with normal serum liver enzymes. BMC Med 9(1):85","journal-title":"BMC Med"},{"issue":"2","key":"4243_CR7","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.jhep.2010.11.028","volume":"55","author":"T Nakano","year":"2011","unstructured":"Nakano T, Cheng YF, Lai CY, Hsu LW, Chang YC, Deng JY, Huang YZ, Honda H, Chen KD, Wang CC, Chiu KW, Jawan B, Eng HL, Goto S, Chen CL (2011) Impact of artificial sunlight therapy on the progress of non-alcoholic fatty liver disease in rats. J Hepatol 55(2):415\u2013425","journal-title":"J Hepatol"},{"issue":"7","key":"4243_CR8","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.numecd.2006.04.002","volume":"17","author":"G Targher","year":"2007","unstructured":"Targher G, Bertolini L, Scala L, Cigolini M, Zenari L, Falezza G, Arcaro G (2007) Associations between serum 25-hydroxyvitamin D 3 concentrations and liver histology in patients with non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis 17(7):517\u2013524","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"4","key":"4243_CR9","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1002\/hep.24737","volume":"55","author":"CL Roth","year":"2012","unstructured":"Roth CL, Elfers CT, Figlewicz DP, Melhorn SJ, Morton GJ, Hoofnagle A, Yeh MM, Nelson JE, Kowdley KV (2012) Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and toll-like receptor activation. Hepatology 55(4):1103\u20131111","journal-title":"Hepatology"},{"issue":"S1","key":"4243_CR10","first-page":"889A","volume":"56","author":"J Dasarathy","year":"2012","unstructured":"Dasarathy J, Periyalwar P, Allampati S, Hawkins CA, Brandl PT, Khiyami A, McCullough AJ, Dasarathy S (2012) Hypovitaminosis D associated with more advanced non-alcoholic fatty liver disease. Hepatology 56(S1):889A-890A","journal-title":"Hepatology"},{"issue":"4","key":"4243_CR11","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1530\/EJE-13-0609","volume":"170","author":"V Nobili","year":"2014","unstructured":"Nobili V, Giorgio V, Liccardo D, Bedogni G, Morino G, Alisi A, Cianfarani S (2014) Vitamin D levels and liver histological alterations in children with nonalcoholic fatty liver disease. Eur J Endocrinol 170(4):547\u2013553","journal-title":"Eur J Endocrinol"},{"key":"4243_CR12","unstructured":"Egyptian growth curves: Egyptian growth curve for boys and girls 2\u201321 years body mass index for age percentile diabetes and endocrine metabolism, Pediatric Unit Cairo University children hospital (2008). http:\/\/dempuegypt.blogspot.com.eg\/"},{"key":"4243_CR13","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.jpeds.2004.06.044","volume":"145","author":"GR Fernandez","year":"2004","unstructured":"Fernandez GR, Redden DT, Pietrobella A, Allison DB (2004) Waist circumference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescents. J Pediatr 145:439\u2013444","journal-title":"J Pediatr"},{"key":"4243_CR14","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1210\/jc.2011-0385","volume":"96","author":"MF Holick","year":"2011","unstructured":"Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96:1911\u20131930","journal-title":"J Clin Endocrinol Metab"},{"issue":"1313","key":"4243_CR15","first-page":"1321","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41(1313):1321","journal-title":"Hepatology"},{"issue":"1","key":"4243_CR16","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/1475-2891-11-78","volume":"11","author":"A Salehpour","year":"2012","unstructured":"Salehpour A, Hosseinpanah F, Shidfar F, Vafa M, Razaghi M, Dehghani S, Hoshiarrad A, Gohari M (2012) A 12-week double-blind randomized clinical trial of vitamin D3 supplementation on body fat mass in healthy overweight and obese women. Nutr J 11(1):78","journal-title":"Nutr J"},{"issue":"1","key":"4243_CR17","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3945\/ajcn.111.019489","volume":"95","author":"JL Rosenblum","year":"2012","unstructured":"Rosenblum JL, Castro VM, Moore CE, Kaplan LM (2012) Calcium and vitamin D supplementation is associated with decreased abdominal visceral adipose tissue in overweight and obese adults. Am J Clin Nutr 95(1):101\u2013108","journal-title":"Am J Clin Nutr"},{"key":"4243_CR18","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.nutres.2008.08.004","volume":"28","author":"SM Siddiqui","year":"2008","unstructured":"Siddiqui SM, Chang E, Li J, Burlage C, Zou M, Buhman KK, Koser S, Donkin SS, Teegarden D (2008) Dietary intervention with vitamin D, calcium, and whey protein reduced fat mass and increased lean mass in rats. Nutr Res 28:783\u2013790","journal-title":"Nutr Res"},{"issue":"9","key":"4243_CR19","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.2337\/db16-0309","volume":"65","author":"S Sisley","year":"2016","unstructured":"Sisley S, Arble DM, Chambers AP, Gutierrez-Aguilar R, He Y, Xu Y, Gardner D, Moore DD, Seeley RJ, Sandoval DA (2016) Hypothalamic vitamin D improves glucose homeostasis and reduces weight. Diabetes 65(9):2732\u20132741","journal-title":"Diabetes"},{"key":"4243_CR20","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.mehy.2008.10.005","volume":"72","author":"YJ Foss","year":"2009","unstructured":"Foss YJ (2009) Vitamin D deficiency is the cause of common obesity. Med Hypothesis 72:314\u2013322","journal-title":"Medical Hypothesis"},{"key":"4243_CR21","doi-asserted-by":"publisher","first-page":"146S","DOI":"10.1080\/07315724.2002.10719212","volume":"21","author":"MB Zemel","year":"2002","unstructured":"Zemel MB (2002) Regulation of adiposity and obesity risk by dietary calcium: mechanisms and implications. J Am Coll Nutr 21:146S-151S","journal-title":"J Am Coll Nutr"},{"issue":"7","key":"4243_CR22","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1210\/js.2017-00472","volume":"2","author":"N Mirhosseini","year":"2018","unstructured":"Mirhosseini N, Vatanparast H, Mazidi M, Kimball SM (2018) Vitamin D supplementation, glycemic control, and insulin resistance in prediabetics: a meta-analysis. J Endocrinol Societ 2(7):687\u2013709","journal-title":"J Endocrinol Societ"},{"issue":"3","key":"4243_CR23","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1096\/fj.02-0424fje","volume":"17","author":"U Zeitz","year":"2003","unstructured":"Zeitz U, Weber K, Soegiarto DW, Wolf E, Balling R, Erben RG (2003) Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor. FASEB J 17(3):509\u2013511","journal-title":"FASEB J"},{"key":"4243_CR24","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.ecl.2010.02.010","volume":"39","author":"M Hewison","year":"2010","unstructured":"Hewison M (2010) Vitamin D and the immune system: new perspectives on an old theme. Endocrinol Metab Clin North Am 39:365\u2013379","journal-title":"Endocrinol Metab Clin North Am"},{"key":"4243_CR25","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1007\/s00125-005-1764-9","volume":"48","author":"H Kolb","year":"2005","unstructured":"Kolb H, Mandrup-Poulsen T (2005) An immune origin of type 2 diabetes? Diabetologia 48:1038\u20131050","journal-title":"Diabetologia"},{"key":"4243_CR26","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1742-1241.2003.tb10480.x","volume":"57","author":"AM Borissova","year":"2003","unstructured":"Borissova AM, Tankova T, Kirilov G, Dakovska L, Kovacheva R (2003) The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. Int J Clin Pract 57:258\u2013261","journal-title":"Int J Clin Pract"},{"key":"4243_CR27","first-page":"E975","volume":"258","author":"GZ Fadda","year":"1990","unstructured":"Fadda GZ, Akmal M, Lipson LG, Massry SG (1990) Direct effect of parathyroid hormone on insulin secretion from pancreatic islets. Am J Physiol 258:E975\u2013E984","journal-title":"Am J Physiol"},{"issue":"9","key":"4243_CR28","first-page":"631","volume":"19","author":"HL Amiri","year":"2016","unstructured":"Amiri HL, Agah S, Mousavi SN, Hosseini AF, Shidfar F (2016) Regression of nonalcoholic fatty liver by vitamin D supplement: a double-blind randomized controlled clinical trial. Arch Iran Med 19(9):631\u2013638","journal-title":"Arch Iran Med"},{"key":"4243_CR29","doi-asserted-by":"crossref","unstructured":"Corte CD, Carpino G, De Vito R, De Stefanis C, Alisi A, Cianfarani S, Overi D, Mosca A, Stronati L, Cucchiara S, Raponi M, Gaudio E, Byme CD, Nobili V (2016) Docosahexanoic acid plus vitamin D treatment improves features of NAFLD in children with serum vitamin D deficiency: results from a single centre trial. PLoS One 11(12): e0168216","DOI":"10.1371\/journal.pone.0168216"},{"issue":"16","key":"4243_CR30","doi-asserted-by":"publisher","first-page":"715","DOI":"10.4254\/wjh.v9.i16.715","volume":"9","author":"M Benedict","year":"2017","unstructured":"Benedict M, Zhang X (2017) Non-alcoholic fatty liver disease: an expended review. World J Hepatol 9(16):715\u2013732","journal-title":"World J Hepatol"},{"key":"4243_CR31","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.jhep.2010.12.026","volume":"55","author":"A Geier","year":"2011","unstructured":"Geier A (2011) Shedding new light on vitamin D and fatty liver disease. J Hepatol 55:273\u2013275","journal-title":"J Hepatol"},{"key":"4243_CR32","doi-asserted-by":"crossref","unstructured":"Ding C, Wilding JP, Bing C (2013) 1,25-Dihydroxyvitamin D3 protects against macrophage-induced activation of NF\u03baB and MAPK signalling and chemokine release in human adipocytes. PLoS One 8: e61707","DOI":"10.1371\/journal.pone.0061707"}],"updated-by":[{"DOI":"10.1007\/s00431-021-04262-1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T00:00:00Z","timestamp":1632441600000}}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-021-04243-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-021-04243-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-021-04243-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T00:41:03Z","timestamp":1699404063000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-021-04243-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,30]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["4243"],"URL":"https:\/\/doi.org\/10.1007\/s00431-021-04243-4","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00431-021-04262-1","asserted-by":"object"}]},"ISSN":["0340-6199","1432-1076"],"issn-type":[{"value":"0340-6199","type":"print"},{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,30]]},"assertion":[{"value":"3 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2021","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00431-021-04262-1","URL":"https:\/\/doi.org\/10.1007\/s00431-021-04262-1","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The local ethics committee of the Faculty of Medicine, Tanta University, approved the study. The study is in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"An informed consent was obtained from the parents of all subjects of the study before enrollment.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All the authors transfer, assign, or otherwise convey all copyright ownership, including any and all rights exclusively to the journal, in the event that such work is published by the journal.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}